Kairos Pharma Announces 1-for-7 Reverse Stock Split for NYSE Compliance

Kairos Pharma has announced a 1-for-7 reverse stock split, a corporate action taken to increase its share price and maintain compliance with NYSE listing requirements, as reported by Morningstar and other outlets.